Vein Removal During Pancreatic Cancer Surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study follows patients who have pancreatic surgery where the surgeon also removes and repairs a nearby vein (portal or superior mesenteric vein) to remove the cancer completely. Researchers want to understand how well this approach works and what happens to patients after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having pancreatic surgery with the goal of completely removing cancer
- Your surgery includes removal and repair of the portal vein or superior mesenteric vein (veins near the pancreas)
- Your surgery is scheduled between June 1, 2026 and June 30, 2027
- You are 18 years old or older
- Cancer has not spread to distant parts of your body
- The surgeon was able to remove all visible cancer (R0 or R1 resection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at pancreatic cancer patients who undergo planned surgery and how surgery-related factors relate to outcomes. It especially focuses on pre-surgery CT scans and the “margin” status from the pathology report, which may help doctors better plan treatment.
This trial studies whether removing extra lymph nodes during surgery for pancreatic cancer can help find if the cancer has spread. It is for patients whose tumor is considered removable or borderline removable.
This study looks at removing certain lymph nodes near the aorta while doing a standard Whipple operation for pancreatic head cancer. The goal is to see whether this approach can improve how well doctors manage the cancer spread.
This study compares two ways of doing pancreaticoduodenectomy (a major surgery to remove parts of the pancreas and nearby tissue): minimally invasive (often smaller incisions) versus open surgery. It may help clarify which approach works best when the cancer looks potentially removable.
This trial tests two different surgical techniques for removing pancreatic cancer tumors that can be surgically removed. Researchers want to see if operating on the main artery first leads to better outcomes than the standard approach.
This trial tests a three-drug chemotherapy combination (gemcitabine, cisplatin, and nab-paclitaxel) given before surgery for people with pancreatic cancer that can be removed or is on the edge of being removable. The goal is to shrink the tumor and improve surgery outcomes.
Hear when a new IPMN, Pancreatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.